Publications
S Russell, A Wrobel, D Skvarc, B Kavanagh, M Ashton, O Dean, M Berk, A Turner
(2023), Vol. 26, pp. 61-69, The international journal of neuropsychopharmacology, C1
Metformin is Protective Against the Development of Mood Disorders
J Lake, C Bortolasci, A Stuart, J Pasco, S Kidnapillai, B Spolding, T Truong, B Panizzutti, Z Liu, O Dean, T Crowley, M Richardson, J Kim, M Berk, L Williams, K Walder
(2023), Vol. 56, pp. 25-31, Pharmacopsychiatry, Germany, C1
G Carter, M Spittal, L Glowacki, D Gerostamoulos, P Dietze, B Sinclair, S Arunogiri, M Berk, D Lubman, V Manning, P Higgs, B Quinn, A Baker, O Dean, A Turner, R McKetin
(2023), Vol. 118, pp. 470-479, Addiction, England, C1
A Walker, M Mohebbi, M Maes, M Berk, K Walder, C Bortolasci, Z Liu, C Ng, M Ashton, L Berk, A Singh, G Malhi, O Dean
(2023), Vol. 27, Brain, Behavior, and Immunity - Health, C1
C Moller, P Badcock, S Hetrick, S Rice, M Berk, K Witt, A Chanen, O Dean, C Gao, S Cotton, C Davey
(2023), pp. 000486742211442-000486742211442, Australian and New Zealand Journal of Psychiatry, England, C1
Childhood trauma and depressive symptoms in bipolar disorder: a network analysis
Anna Wrobel, Sue Cotton, Anuradhi Jayasinghe, Claudia Diaz‐Byrd, Anastasia Yocum, Alyna Turner, Olivia Dean, Samantha Russell, Elizabeth Duval, Tobin Ehrlich, David Marshall, Michael Berk, Melvin McInnis
(2023), Vol. 147, pp. 286-300, Acta Psychiatrica Scandinavica, London, Eng., C1
Samantha Russell, David Skvarc, Mohammadreza Mohebbi, David Camfield, Linda Byrne, Alyna Turner, Melanie Ashton, Michael Berk, Seetal Dodd, Gin Malhi, Sue Cotton, Ashley Bush, Olivia Dean
(2023), Vol. 21, pp. 320-331, Clinical Psychopharmacology and Neuroscience, Seoul, Korea, C1-1
Chiara Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Trang Truong, Timothy Connor, Courtney Swinton, Bruna Panizzutti, Zoe Liu, Andrew Sanigorski, Olivia Dean, Tamsyn Crowley, Mark Richardson, Kiymet Bozaoglu, Katerina Vlahos, Stephanie Cowdery, Brad Watmuff, Stephan Steyn, De Wolmarans, Barend Engelbrecht, Christina Perry, Katherine DRUMMOND, Terence Pang, Stéphane Jamain, Laura Gray, Sean McGee, Brian Harvey, Jee Kim, Marion Leboyer, Michael Berk, Ken Walder
(2023), pp. 1-10, Bipolar Disorders, London, Eng., C1
Bruna Panizzutti, David Skvarc, Sylvia Lin, Sarah Croce, Alcy Meehan, Chiara Bortolasci, Wolfgang Marx, Adam Walker, Kyoko Hasebe, Bianca Kavanagh, Margaret Morris, Mohammadreza Mohebbi, Alyna Turner, Laura Gray, Lesley Berk, Ken Walder, Michael Berk, Olivia Dean
(2023), Vol. 24, pp. 1-28, International Journal of Molecular Sciences, Basel, Switzerland, C1-1
A Wrobel, S Russell, A Jayasinghe, M Lotfaliany, A Turner, O Dean, S Cotton, C Diaz-Byrd, A Yocum, E Duval, T Ehrlich, D Marshall, M Berk, M McInnis
(2023), Vol. 84, The Journal of clinical psychiatry, Memphis, Tenn., C1
Childhood trauma relates to worse memory functioning in bipolar disorder
T Ehrlich, H Kim, K Ryan, S Langenecker, E Duval, A Yocum, C Diaz-Byrd, A Wrobel, O Dean, S Cotton, M Berk, M McInnis, D Marshall
(2023), Vol. 333, pp. 377-383, Journal of Affective Disorders, C1
R Zazula, S Dodd, O Dean, M Berk, C Bortolasci, W Verri, H Vargas, S Nunes
(2022), Vol. 23, pp. 67-77, World Journal of Biological Psychiatry, England, C1
R Zazula, M Mohebbi, S Dodd, O Dean, M Berk, H Vargas, S Nunes
(2022), Vol. 37, pp. 376-389, Archives of Clinical Neuropsychology, United States, C1
A Wrobel, A Jayasinghe, S Russell, W Marx, L Alameda, O Dean, S Cotton, M Berk, A Turner
(2022), Vol. 296, pp. 350-362, Journal of Affective Disorders, Amsterdam, The Netherlands, C1
B Mitchell, A Campos, D Whiteman, C Olsen, S Gordon, A Walker, O Dean, M Berk, I Hickie, S Medland, N Wray, N Martin, E Byrne
(2022), Vol. 92, pp. 227-235, Biological Psychiatry, United States, C1
Seetal Dodd, David Skvarc, Olivia Dean, Anna Anderson, Mark Kotowicz, Michael Berk
(2022), Vol. 25, pp. 387-398, International Journal of Neuropsychopharmacology, Oxford, Eng., C1
A Wrobel, O Köhler‐Forsberg, L Sylvia, S Russell, O Dean, S Cotton, M Thase, J Calabrese, T Deckersbach, M Tohen, C Bowden, M McInnis, J Kocsis, E Friedman, T Ketter, R Shelton, M Ostacher, D Iosifescu, M Berk, A Turner, A Nierenberg
(2022), Vol. 145, pp. 615-627, Acta Psychiatrica Scandinavica, London, England, C1
Anna Wrobel, Samantha Russell, Anuradhi Jayasinghe, Mojtaba Lotfaliany, Alyna Turner, Olivia Dean, Sue Cotton, Claudia Diaz‐Byrd, Anastasia Yocum, Elizabeth Duval, Tobin Ehrlich, David Marshall, Michael Berk, Melvin McInnis
(2022), Vol. 145, pp. 591-603, Acta Psychiatrica Scandinavica, London, Eng., C1
J Sarris, G Byrne, D Castle, C Bousman, G Oliver, L Cribb, S Blair-West, V Brakoulias, D Camfield, C Ee, S Chamoli, M Boschen, O Dean, N Dowling, R Menon, J Murphy, N Metri, T Nguyen, A Wong, R Jordan, D Karamacoska, S Rossell, M Berk, C Ng
(2022), Vol. 117, pp. 1-9, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
J Sarris, A Ravindran, L Yatham, W Marx, J Rucklidge, R McIntyre, S Akhondzadeh, F Benedetti, C Caneo, H Cramer, L Cribb, M de Manincor, O Dean, A Deslandes, M Freeman, B Gangadhar, B Harvey, S Kasper, J Lake, A Lopresti, L Lu, N Metri, D Mischoulon, C Ng, D Nishi, R Rahimi, S Seedat, J Sinclair, K Su, Z Zhang, M Berk
(2022), pp. 1-32, World Journal of Biological Psychiatry, London, Eng., C1
Common effects of bipolar disorder medications on expression quantitative trait loci genes
T Truong, C Bortolasci, S Kidnapillai, B Spolding, B Panizzutti, Z Liu, B Watmuff, J Kim, O Dean, M Richardson, M Berk, K Walder
(2022), Vol. 150, pp. 105-112, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1
Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Zoe Liu, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Craig Smith, Olivia Dean, Jee Kim, Michael Berk, Ken Walder
(2022), Vol. 13, pp. 1-12, Frontiers in Pharmacology, Lausanne, Switzerland, C1
Samantha Russell, Anna Wrobel, Olivia Dean, Michael Berk, Seetal Dodd, Chee Ng, Gin Malhi, Susan Cotton, Jerome Sarris, Alyna Turner
(2022), Vol. 20, pp. 300-310, Clinical psychopharmacology and neuroscience, Seoul, Korea (South), C1
Effects of psychotropic drugs on ribosomal genes and protein synthesis
Zoe Liu, Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Courtney Swinton, Jee Kim, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Olivia Dean, Sean McGee, Michael Berk, Ken Walder
(2022), Vol. 23, pp. 7180-7180, International Journal of Molecular Sciences, Basel, Switzerland, C1
Integrative analyses of transcriptomes to explore common molecular effects of antipsychotic drugs
Trang Truong, Chiara Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Bruna Panizzutti, Zoe Liu, Jee Kim, Olivia Dean, Mark Richardson, Michael Berk, Ken Walder
(2022), Vol. 23, pp. 7508-7508, International Journal of Molecular Sciences, Basel, Switzerland, C1
Erica Neill, Susan Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael Berk, Kiymet Bozaoglu, Frances Dark, Olivia Dean, Paul Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David Castle
(2022), pp. 1-10, Schizophrenia Bulletin, Oxford, Eng., C1
A Wrobel, S Russell, A Jayasinghe, B Kavanagh, M Lotfaliany, A Turner, O Dean, S Cotton, C Diaz-Byrd, A Yocum, E Duval, T Ehrlich, D Marshall, M Berk, M McInnis
(2022), Australian and New Zealand Journal of Psychiatry, England, C1
C Moller, P Badcock, S Hetrick, S Rice, M Berk, O Dean, A Chanen, C Gao, C Davey, S Cotton
(2022), Omega (United States), United States, C1
K Fountoulakis, E Dragioti, A Theofilidis, T Wiklund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadaǧ, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert
(2021), Vol. 26, pp. 290-298, CNS Spectrums, United States, C1
A novel way to quantify schizophrenia symptoms in clinical trials
O Medvedev, M Berk, O Dean, E Brown, M Sandham, J Dipnall, R McNamara, A Sumich, C Krägeloh, A Narayanan, R Siegert
(2021), Vol. 51, European Journal of Clinical Investigation, England, C1
A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder
M Ashton, B Kavanagh, W Marx, M Berk, J Sarris, C Ng, M Hopwood, L Williams, O Dean
(2021), Vol. 66, pp. 262-273, Canadian Journal of Psychiatry, United States, C1
R McKETIN, B Quinn, P Higgs, M Berk, O Dean, A Turner, P Kelly, D Lubman, G Carter, A Baker, V Manning, T Thomas, R Bathish, D Raftery, L Saunders, A Wrobel, A Meehan, B Sinclair, D Reid, S Arunogiri, H Hill, F Cordaro, P Dietze
(2021), Vol. 40, pp. 1249-1255, Drug and Alcohol Review, Australia, C1
R Zazula, M Husain, M Mohebbi, A Walker, I Chaudhry, A Khoso, M Ashton, B Agustini, N Husain, J Deakin, A Young, M Berk, B Kanchanatawan, C Ng, M Maes, L Berk, A Singh, G Malhi, O Dean
(2021), Vol. 55, pp. 784-798, Australian and New Zealand Journal of Psychiatry, England, C1
B Kavanagh, M Ashton, S Cowdery, O Dean, A Turner, M Berk, S Gwini, S Brennan-Olsen, H Koivumaa-Honkanen, A Chanen, L Williams
(2021), Vol. 279, pp. 711-721, Journal of affective disorders, Amsterdam, The Netherlands, C1
C Moller, S Cotton, P Badcock, S Hetrick, M Berk, O Dean, A Chanen, C Davey
(2021), Vol. 281, pp. 714-720, Journal of Affective Disorders, Netherlands, C1
A Turner, A Baker, O Dean, A Walker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk
(2021), Vol. 66, pp. 354-366, Canadian Journal of Psychiatry, United States, C1
T Purton, L Staskova, M Lane, S Dawson, M West, J Firth, G Clarke, J Cryan, M Berk, A O'Neil, O Dean, A Hadi, C Honan, W Marx
(2021), Vol. 123, pp. 1-13, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
L Arancini, R Borland, M Le Grande, M Mohebbi, S Dodd, O Dean, M Berk, A McNeill, G Fong, K Cummings
(2021), Vol. 116, pp. 2509-2520, Addiction, England, C1
K Witt, T Madsen, M Berk, O Dean, A Chanen, P McGorry, S Cotton, C Davey, S Hetrick
(2021), Vol. 55, pp. 506-516, Australian and New Zealand Journal of Psychiatry, England, C1
Bianca Kavanagh, Stella Gwini, Julie Pasco, Amanda Stuart, Shae Quirk, James Gaston, Kara Holloway-Kew, Alyna Turner, Michael Berk, Olivia Dean, Andrew Chanen, Heli Koivumaa-Honkanen, Paul Moran, Rohan Borschmann, Lana Williams
(2021), Vol. 2, pp. 1-8, Frontiers in Global Women's Health, Lausanne, Switzerland, C1
A Wrobel, S Russell, O Dean, S Cotton, M Berk, A Turner
(2021), Vol. 11, pp. 1-8, BMJ open, London, Eng., C1
D Raftery, P Kelly, F Deane, G Carter, O Dean, D Lubman, A Turner, R McKetin
(2021), Vol. 130, Journal of Substance Abuse Treatment, United States, C1
W Marx, D Skvarc, M Mohebbi, A Walker, A Meehan, A Turner, A Baker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk, O Dean
(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1
J Sarris, G Byrne, G Oliver, L Cribb, S Blair-West, D Castle, O Dean, D Camfield, V Brakoulias, C Bousman, N Dowling, C Ee, J Murphy, R Menon, M Berk, S Chamoli, M Boschen, C Ng
(2021), CNS Spectrums, United States, C1
B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, G Morris, L Gray, J Kim, O Dean, M Berk, K Walder
(2021), Vol. 22, International Journal of Molecular Sciences, Switzerland, C1
Statins: Neurobiological underpinnings and mechanisms in mood disorders
A Walker, Y Kim, I Borissiouk, R Rehder, S Dodd, G Morris, A Nierenberg, M Maes, B Fernandes, O Dean, L Williams, H Eyre, S Kim, S Zoungas, A Carvalho, M Berk
(2021), Vol. 128, pp. 693-708, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial
R McKetin, O Dean, A Turner, P Kelly, B Quinn, D Lubman, P Dietze, G Carter, P Higgs, B Sinclair, D Reid, A Baker, V Manning, N Pas, T Thomas, R Bathish, D Raftery, A Wrobel, L Saunders, S Arunogiri, F Cordaro, H Hill, S Hall, P Clare, M Mohebbi, M Berk
(2021), Vol. 38, eClinicalMedicine, England, C1
C Bortolasci, A Turner, M Mohebbi, Z Liu, M Ashton, L Gray, W Marx, A Walker, G Kowalski, F Jacka, M Berk, O Dean, K Walder
(2021), Vol. 142, pp. 376-383, Journal of Psychiatric Research, England, C1
K Fountoulakis, E Dragioti, A Theofilidis, T Wiklund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadağ, A de Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M de Hert
(2021), CNS Spectrums, United States, C1
Biological mechanism(S) underpinning the association between antipsychotic drugs and weight gain
B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, L Gray, J Kim, O Dean, M Berk, K Walder
(2021), Vol. 10, Journal of Clinical Medicine, Switzerland, C1
L Arancini, M Mohebbi, M Berk, O Dean, C Bortolasci, B Spolding, R Zazula, S Dodd
(2021), Vol. 53, pp. 120-126, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1
Dietary quality and nutrient intake in adults with obsessive-compulsive disorder
T Nguyen, L Cribb, C Ng, G Byrne, D Castle, V Brakoulias, S Blair-West, G Oliver, C Ee, O Dean, D Camfield, C Bousman, N Dowling, R Roy, M Berk, J Sarris
(2021), Vol. 7, BJPsych Open, C1
K Hasebe, M Mohebbi, L Gray, A Walker, C Bortolasci, A Turner, M Berk, K Walder, M Maes, B Kanchanatawan, M Ashton, L Berk, C Ng, G Malhi, A Singh, O Dean
(2021), Vol. 34, Acta Neuropsychiatrica, England, C1
Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review
C Yolland, A Phillipou, D Castle, E Neill, M Hughes, C Galletly, Z Smith, P Francis, O Dean, J Sarris, D Siskind, A Harris, S Rossell
(2020), Vol. 23, pp. 139-148, Nutritional neuroscience, Abingdon, Eng., C1
The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder
S Kidnapillai, C Bortolasci, M Udawela, B Panizzutti, B Spolding, T Connor, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, E Scarr, M Leboyer, B Dean, M Berk, K Walder
(2020), Vol. 21, pp. 775-783, World Journal of Biological Psychiatry, England, C1
N Travica, N D'Cunha, N Naumovski, K Kent, D Mellor, J Firth, E Georgousopoulou, O Dean, A Loughman, F Jacka, W Marx
(2020), Vol. 85, pp. 96-105, Brain, Behavior, and Immunity, Netherlands, C1
Bianca Kavanagh, Lana Williams, Michael Berk, Alyna Turner, Henry Jackson, Mohammadreza Mohebbi, Buranee Kanchanatawan, Melanie Ashton, Chee Ng, Michael Maes, Lesley Berk, Gin Malhi, Nathan Dowling, Ajeet Singh, Olivia Dean
(2020), Vol. 42, pp. 14-21, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
M Ashton, O Dean, W Marx, M Mohebbi, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, K Faye-Chauhan, Y Kim, S Dash, F Jacka, N Shivappa, J Hebert, A Turner
(2020), Vol. 54, pp. 159-172, Australian and New Zealand journal of psychiatry, London, Eng., C1
W Marx, M Hockey, A McGuinness, M Lane, J Christodoulou, I van der Mei, M Berk, O Dean, B Taylor, S Broadley, J Lechner-Scott, F Jacka, R Lucas, A Ponsonby
(2020), Vol. 37, Multiple Sclerosis and Related Disorders, Netherlands, C1
M Ashton, M Mohebbi, A Turner, W Marx, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, B Stubbs, O Dean
(2020), Vol. 65, pp. 306-318, Canadian journal of psychiatry, London, Eng., C1
C Yolland, D Hanratty, E Neill, S Rossell, M Berk, O Dean, D Castle, E Tan, A Phillipou, A Harris, A Barreiros, A Hansen, D Siskind
(2020), Vol. 54, pp. 453-466, Australian and New Zealand journal of psychiatry, London, Eng., C1
M Berk, M Mohebbi, O Dean, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Weller, A MacKinnon, F Giorlando, S Baird, L Incerti, R Brodie, N Ferguson, S Rice, M Schäfer, E Mullen, S Hetrick, M Kerr, S Harrigan, A Quinn, C Mazza, P McGorry, C Davey
(2020), Vol. 18, BMC Medicine, England, C1
C Bortolasci, W Marx, A Walker, K Hasebe, B Kavanagh, M Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, O Dean
(2020), Vol. 10, pp. e035080-, BMJ open, England, C1
J Lotter, M Möller, O Dean, M Berk, B Harvey
(2020), Vol. 11, Frontiers in Psychiatry, Switzerland, C1
C Bortolasci, C Voigt, A Turner, M Mohebbi, L Gray, S Dodd, K Walder, M Berk, S Cotton, G Malhi, C Ng, N Dowling, J Sarris, O Dean
(2020), Vol. 32, pp. 313-320, Acta Neuropsychiatrica, England, C1
Personality disorder increases risk of low quality of life among women with mental state disorders
B Kavanagh, A Stuart, M Berk, A Turner, O Dean, J Pasco, H Jackson, H Koivumaa-Honkanen, A Chanen, L Williams
(2020), Vol. 102, Comprehensive Psychiatry, United States, C1
Insight in substance use disorder: A systematic review of the literature
D Raftery, P Kelly, F Deane, A Baker, I Ingram, M Goh, D Lubman, G Carter, A Turner, O Dean, B Sinclair, R McKetin
(2020), Vol. 111, Addictive Behaviors, England, C1
Wolfgang Marx, Andrew Scholey, Joseph Firth, Nathan D’Cunha, Melissa Lane, Meghan Hockey, Melanie Ashton, John Cryan, A O'Neil, Nenad Naumovski, Michael Berk, Olivia Dean, Felice Jacka
(2020), Vol. 118, pp. 472-484, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1
Transcriptional effects of psychoactive drugs on genes involved in neurogenesis
C Bortolasci, B Spolding, S Kidnapillai, T Connor, T Truong, Z Liu, B Panizzutti, M Richardson, L Gray, M Berk, O Dean, K Walder
(2020), Vol. 21, pp. 1-19, International Journal of Molecular Sciences, Switzerland, C1
J Scott, A Baker, C Lim, S Foley, F Dark, A Gordon, D Ward, D Richardson, G Bruxner, K Beckmann, S Hatherill, S Stathis, K Dixon, A Ryan, B McWhinney, J Ungerer, M Berk, O Dean, S Saha, J McGrath
(2020), Vol. 3, pp. e2024335-, JAMA network open, United States, C1
Exploring A-Acetylcysteine in Psychiatry
A Gimenez-Palomo, S Dodd, O Dean, C Bortolasci, M Berk
(2020), Vol. 37, pp. 48-51, Psychiatric Times, Santa Ana, Calif., C1-1
E Gliddon, V Cosgrove, L Berk, S Lauder, M Mohebbi, D Grimm, S Dodd, C Coulson, K Raju, T Suppes, M Berk
(2019), Vol. 21, pp. 28-39, Bipolar Disorders, London, Eng., C1
O Dean, K Gray, S Dodd, K Villagonzalo, E Brown, B Tonge, M Berk, L Byrne
(2019), Vol. 44, pp. 474-480, Journal of Intellectual and Developmental Disability, C1
Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean
(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
P Ellegaard, R Licht, R Nielsen, O Dean, M Berk, H Poulsen, M Mohebbi, C Nielsen
(2019), Vol. 245, pp. 1043-1051, Journal of Affective Disorders, Netherlands, C1
M Berk, A Turner, G Malhi, C Ng, S Cotton, S Dodd, Y Samuni, M Tanious, C McAulay, N Dowling, J Sarris, L Owen, A Waterdrinker, D Smith, O Dean
(2019), Vol. 17, BMC Medicine, England, C1
M Ashton, O Dean, A Walker, C Bortolasci, C Ng, M Hopwood, B Harvey, M Möller, J McGrath, W Marx, A Turner, S Dodd, J Scott, J Khoo, K Walder, J Sarris, M Berk
(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1
Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk
(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1
M Ashton, M Berk, C Ng, M Hopwood, B Kavanagh, L Williams, J Sarris, O Dean
(2019), Vol. 9, BMJ Open, England, C1
C Lim, A Baker, S Saha, S Foley, A Gordon, D Ward, B Burgher, F Dark, M Beckmann, S Stathis, G Bruxner, A Ryan, D Richardson, S Hatherill, M Berk, O Dean, J McGrath, J Chapman, S Patterson, S Singh, B Mowry, L Tracy, M Duhig, A Machin, E Troman, S Suetani, T Dinala, L Burton, P Cosgrove, C Gamble, J Scott
(2019), Vol. 20, Trials, England, C1
Wolfgang Marx, Melissa Lane, Tetyana Rocks, Anu Ruusunen, Amy Loughman, Adrian Lopresti, Skye Marshall, Michael Berk, Felice Jacka, Olivia Dean
(2019), Vol. 77, pp. 557-571, Nutrition reviews, Oxford, Eng., C1
R McKetin, O Dean, A Turner, P Kelly, B Quinn, D Lubman, P Dietze, G Carter, P Higgs, A Baker, B Sinclair, D Reid, V Manning, N Te Pas, W Liang, T Thomas, R Bathish, M Kent, D Raftery, S Arunogiri, F Cordaro, H Hill, M Berk
(2019), Vol. 20, Trials, England, C1
D Raftery, P Kelly, F Deane, R Mcketin, A Baker, A Turner, O Dean
(2019), Vol. 38, pp. 622-629, Drug and alcohol review, Chichester, Eng., C1
C Davey, A Chanen, S Hetrick, S Cotton, A Ratheesh, G Amminger, J Koutsogiannis, M Phelan, E Mullen, B Harrison, S Rice, A Parker, O Dean, A Weller, M Kerr, A Quinn, L Catania, N Kazantzis, P McGorry, M Berk
(2019), Vol. 6, pp. 735-744, The Lancet Psychiatry, England, C1
Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline
K Hasebe, L Rivera, C Smith, T Allnutt, T Crowley, T Nelson, O Dean, S McGee, K Walder, L Gray
(2019), Vol. 82, pp. 309-318, Brain, Behavior, and Immunity, Netherlands, C1
L Arancini, C Bortolasci, S Dodd, O Dean, M Berk
(2019), Vol. 20, Trials, England, C1
S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder
(2019), Vol. 20, pp. 766-777, World Journal of Biological Psychiatry, London, Eng., C1
Staging of Schizophrenia with the Use of PANSS: An International Multi-Center Study
K Fountoulakis, E Dragioti, A Theofilidis, T Wikilund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Injac Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadaǧ, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert
(2019), Vol. 22, pp. 681-697, International Journal of Neuropsychopharmacology, Oxford, Eng., C1
S Cotton, M Berk, A Watson, S Wood, K Allott, C Bartholomeusz, C Bortolasci, K Walder, B O'Donoghue, O Dean, A Chanen, G Amminger, P McGorry, A Burnside, J Uren, A Ratheesh, S Dodd
(2019), Vol. 20, Trials, England, C1
A Quinn, O Dean, C Davey, M Kerr, S Harrigan, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, M Schäfer, E Mullen, S Hetrick, P McGorry, M Berk
(2018), Vol. 12, pp. 45-54, Early Intervention in Psychiatry, Australia, C1
I Oberholzer, M Möller, B Holland, O Dean, M Berk, B Harvey
(2018), Vol. 33, pp. 467-480, Metabolic Brain Disease, United States, C1
D Skvarc, M Berk, L Byrne, O Dean, S Dodd, M Lewis, A Marriott, E Moore, G Morris, R Page, L Gray
(2018), Vol. 84, pp. 116-133, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
An update on adjunctive treatment options for bipolar disorder
O Dean, E Gliddon, T Van Rheenen, F Giorlando, S Davidson, M Kaur, T Ngo, L Williams
(2018), Vol. 20, pp. 87-96, Bipolar Disorders, Denmark, C1
Mechanisms underpinning the polypharmacy effects of medications in psychiatry
C Bortolasci, B Spolding, E Callaly, S Martin, B Panizzutti, S Kidnapillai, T Connor, K Hasebe, M Mohebbi, O Dean, S McGee, S Dodd, L Gray, M Berk, K Walder
(2018), Vol. 21, pp. 582-591, International Journal of Neuropsychopharmacology, England, C1
Mitochondrial agents for bipolar disorder
C Pereira, V Chavarria, J Vian, M Ashton, M Berk, W Marx, O Dean
(2018), Vol. 21, pp. 550-569, International Journal of Neuropsychopharmacology, England, C1
P Ellegaard, R Licht, H Poulsen, R Nielsen, M Berk, O Dean, M Mohebbi, C Nielsen
(2018), Vol. 6, International Journal of Bipolar Disorders, Germany, C1
M Mohebbi, S Dodd, O Dean, M Berk
(2018), Vol. 53, pp. 17-22, European Psychiatry, England, C1
B Panizzutti, C Bortolasci, K Hasebe, S Kidnapillai, L Gray, K Walder, M Berk, M Mohebbi, S Dodd, C Gama, P Magalhães, S Cotton, F Kapczinski, A Bush, G Malhi, O Dean
(2018), Vol. 30, pp. 334-341, Acta Neuropsychiatrica, England, C1
A potential role for N-acetylcysteine in the management of methamphetamine dependence
R McKetin, O Dean, A Baker, G Carter, A Turner, P Kelly, M Berk
(2017), Vol. 36, pp. 153-159, Drug and Alcohol Review, Australia, C1
O Dean, K Gray, K Villagonzalo, S Dodd, M Mohebbi, T Vick, B Tonge, M Berk
(2017), Vol. 51, pp. 241-249, Australian and New Zealand Journal of Psychiatry, England, C1
Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean
(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1
Cognitive effects of adjunctive N-acetyl cysteine in psychosis
M Rapado-Castro, S Dodd, A Bush, G Malhi, D Skvarc, Z On, M Berk, O Dean
(2017), Vol. 47, pp. 866-876, Psychological Medicine, C1
A model of the mitochondrial basis of bipolar disorder
G Morris, K Walder, S McGee, O Dean, S Tye, M Maes, M Berk
(2017), Vol. 74, pp. 1-20, Neuroscience and Biobehavioral Reviews, United States, C1
F Jacka, A O'Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, S Dash, C Mihalopoulos, M Chatterton, L Brazionis, O Dean, A Hodge, M Berk
(2017), Vol. 15, BMC Medicine, England, C1
A review of the theoretical and biological understanding of the nocebo and placebo phenomena
S Dodd, O Dean, J Vian, M Berk
(2017), Vol. 39, pp. 469-476, Clinical therapeutics, Amsterdam, The Netherlands, C1
K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean
(2017), Vol. 29, pp. 337-346, Acta Neuropsychiatrica, England, C1
A Ryan, A Baker, F Dark, S Foley, A Gordon, S Hatherill, S Stathis, S Saha, G Bruxner, M Beckman, D Richardson, M Berk, O Dean, J McGrath, C Group, J Scott
(2017), Vol. 18, Trials, England, C1
the effect of n-acetylcysteine (nac) on human cognition - a systematic review
D Skvarc, O Dean, L Byrne, L Gray, S Lane, M Lewis, B Fernandes, M Berk, A Marriott
(2017), Vol. 78, pp. 44-56, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk
(2017), Vol. 51, pp. 829-840, Australian and New Zealand Journal of Psychiatry, England, C1
R Menon, L Cribb, J Murphy, M Ashton, G Oliver, N Dowling, A Turner, O Dean, M Berk, C Ng, J Sarris
(2017), Vol. 4, pp. 109-114, Advances in integrative medicine, Amsterdam, The Netherlands, C1
B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonçalves, M Berk
(2016), Vol. 21, pp. 554-564, Molecular Psychiatry, England, C1
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
J Davis, H Eyre, F Jacka, S Dodd, O Dean, S McEwen, M Debnath, J McGrath, M Maes, P Amminger, P McGorry, C Pantelis, M Berk
(2016), Vol. 65, pp. 185-194, Neuroscience and Biobehavioral Reviews, United States, C1
Antioxidant treatments for schizophrenia
P Magalhães, O Dean, A Andreazza, M Berk, F Kapczinski
(2016), Vol. 2016, Cochrane Database of Systematic Reviews, England, C1
N-acetylcysteine in depressive symptoms and functionality: A systematic review and meta-analysis
B Fernandes, O Dean, S Dodd, G Malhi, M Berk
(2016), Vol. 77, pp. e457-e466, Journal of Clinical Psychiatry, United States, C1
D Skvarc, O Dean, L Byrne, L Gray, K Ives, S Lane, M Lewis, C Osborne, R Page, D Stupart, A Turner, M Berk, A Marriott
(2016), Vol. 17, Trials, England, C1
S Rossell, P Francis, C Galletly, A Harris, D Siskind, M Berk, K Bozaoglu, F Dark, O Dean, D Liu, D Meyer, E Neill, A Phillipou, J Sarris, D Castle
(2016), Vol. 16, BMC Psychiatry, England, C1
J Sarris, G Oliver, D Camfield, O Dean
(2016), Vol. 4, pp. 1104-1111, Clinical psychological science, London, Eng., C1
The use of mixed methods in drug discovery: integrating qualitative methods into clinical trials
M Berk, R Otmar, O Dean, L Berk, E Michalak
(2015), pp. 59-73, Clinical trial design challenges in mood disorders, Amsterdam, The Netherlands, B1
M Rapado-Castro, M Berk, K Venugopal, A Bush, S Dodd, O Dean
(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1
Oxidative stress and post-stroke depression: possible therapeutic role of polyphenols?
S Nabavi, O Dean, A Turner, A Sureda, M Daglia, S Nabavi
(2015), Vol. 22, pp. 343-351, Current medicinal chemistry, Beijing, China, C1-1
Tobacco use in bipolar disorder.
D Thomson, M Berk, S Dodd, M Rapado-Castro, S Quirk, P Ellegaard, L Berk, O Dean
(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1
G Oliver, O Dean, D Camfield, S Blair-West, C Ng, M Berk, J Sarris
(2015), Vol. 13, pp. 12-24, Clinical psychopharmacology and neuroscience, Korea (South), C1
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Deepmala, J Slattery, N Kumar, L Delhey, M Berk, O Dean, C Spielholz, R Frye
(2015), Vol. 55, pp. 294-321, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1
J Sarris, G Oliver, D Camfield, O Dean, N Dowling, D Smith, J Murphy, R Menon, M Berk, S Blair-West, C Ng
(2015), Vol. 29, pp. 801-809, CNS Drugs, Berlin, Germany, C1
Future directions for pharmacotherapies for treatment-resistant bipolar disorder
S Dodd, B Simoes Fernandes, O Dean
(2015), Vol. 13, pp. 656-662, Current neuropharmacology, Bussum, The Netherlands, C1
G Anderson, M Berk, O Dean, S Moylan, M Maes
(2014), Vol. 28, CNS Drugs, Aukland, New Zealand, C1
Post-stroke depression therapy: where are we now?
S Nabavi, A Turner, O Dean, A Sureda, S Nabavi
(2014), Vol. 11, pp. 1-13, Current neurovascular research, Bussum, The Netherlands, C1
M Berk, O Dean, S Cotton, S Jeavons, M Tanious, K Kohlmann, K Hewitt, K Moss, C Allwang, I Schapkaitz, J Robbins, H Cobb, F Ng, S Dodd, A Bush, G Malhi
(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1
Oxidative & nitrosative stress in depression: why so much stress?
S Moylan, M Berk, O Dean, Y Samuni, L Williams, A O'Neil, A Hayley, J Pasco, G Anderson, F Jacka, M Maes
(2014), Vol. 45, pp. 46-62, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1
O Dean, A Turner, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, Y Samuni, M Tanious, N Dowling, A Waterdrinker, D Smith, M Berk
(2014), Vol. 0, pp. 1-10, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1
The Glutathione System: a new drug target in neuroimmune disorders
G Morris, G Anderson, O Dean, M Berk, P Galecki, M Martin-Subero, M Maes
(2014), Vol. 50, pp. 1059-1084, Molecular neurobiology, New York, N. Y., C1
C Davey, A Chanen, S Cotton, S Hetrick, M Kerr, M Berk, O Dean, K Yuen, M Phelan, A Ratheesh, M Schäfer, G Amminger, A Parker, D Piskulic, S Harrigan, A Mackinnon, B Harrison, P McGorry
(2014), Vol. 15, pp. 1-9, Trials, London, Eng., C1
O Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, A Sughondhabirom, S Tangwongchai, C Ng, N Dowling, G Malhi, M Berk
(2014), Vol. 12, pp. 180-188, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1
Putative neuroprotective agents in neuropsychiatric disorders
S Dodd, M Maes, G Anderson, O Dean, S Moylan, M Berk
(2013), Vol. 42, pp. 135-145, Progress in neuro-psychopharmacology and biological psychiatry, United States, C1
The promise of N-acetylcysteine in neuropsychiatry
M Berk, G Malhi, L Gray, O Dean
(2013), Vol. 34, pp. 167-177, Trends in pharmacological sciences, Oxford, England, C1
P Das, M Tanious, K Fritz, S Dodd, O Dean, M Berk, G Malhi
(2013), Vol. 47, pp. 347-354, Australian and New Zealand journal of psychiatry, London, England, C1
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania
P Vieira da Silva Magalhaes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2013), Vol. 47, pp. 564-568, Australian and New Zealand journal of psychiatry, London, England, C1
Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness
M Berk, O Dean, H Drexhage, J McNeil, S Moylan, A O'Neil, C Davey, L Sanna, M Maes
(2013), Vol. 11, pp. 1-17, BMC medicine, London, England, C1
A O'Neil, M Berk, C Itsiopoulos, D Castle, R Opie, J Pizzinga, L Brazionis, A Hodge, C Mihalopoulos, M Chatterton, O Dean, F Jacka
(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1
The chemistry and biological activities of N-acetylcysteine
Y Samuni, S Goldstein, O Dean, M Berk
(2013), Vol. 1830, pp. 4117-4129, Biochim biophys acta, Amsterdam, Netherlands, C1
H Kalra, O Dean, S Dodd, M Berk
(2012), pp. 95-107, Antidepressants and Major Depressive Disorder, B1-1
Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder
P Magalhaes, O Dean, A Bush, D Copolov, D Weisinger, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2012), Vol. 37, pp. 132-135, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1
Minocycline : therapeutic potential in psychiatry
O Dean, J Data-Franco, F Giorlando, M Berk
(2012), Vol. 26, pp. 391-401, CNS Drugs, Auckland, New Zealand, C1
M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi
(2012), Vol. 10, pp. 1-11, BMC medicine, London, England, C1
Adjunctive antioxidants for bipolar disorder
P Magalhaes, O Dean, A Andreazza, M Berk, F Kapczinski
(2012), pp. 1-11, The Cochrane collaboration, Oxford, England, C1-1
Effects of N-acetyl cysteine on cognitive function in bipolar disorder
O Dean, A Bush, D Copolov, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2012), Vol. 66, pp. 514-517, Psychiatry and clinical neurosciences, Richmond, Vic., C1
M Berk, A Munib, O Dean, G Malhi, K Kohlmann, I Schapkaitz, S Jeavons, F Katz, M Anderson-Hunt, P Conus, B Hanna, R Otmar, F Ng, D Copolov, A Bush
(2011), Vol. 72, pp. 909-913, Journal of clinical psychiatry, [Memphis, Tenn.], C1-1
N-acetylcysteine in psychiatry - current therapeutic evidence and potential mechanisms of action
O Dean, F Giorlando, M Berk
(2011), Vol. 36, pp. 78-86, Journal of psychiatry and neuroscience, Ottowa, Canada, C1-1
O Dean, M van den Buuse, M Berk, D Copolov, C Mavros, A Bush
(2011), Vol. 499, pp. 149-153, Neuroscience letters, Clare, Ireland, C1-1
M Gerlach, G Bartoszyk, P Riederer, O Dean, M van den Buuse
(2011), Vol. 118, pp. 1733-1742, Journal of neural transmission, Amsterdam, The Netherlands, C1-1
Antioxidant treatments for schizophrenia
P Magalhaes, A Andreazza, M Berk, F Kapczinski, O Dean
(2011), pp. 1-13, Cochrane database of systematic reviews, Oxford, U. K., C1-1
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 129, pp. 317-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1
Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder.
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 23, pp. 87-88, Acta neuropsychiatrica, Oxford, England, C1-1
M Berk, F Kapczinski, A Andreazza, O Dean, F Giorlando, M Maes, M Yücel, C Gama, S Dodd, B Dean, P Magalhães, P Amminger, P McGorry, G Malhi
(2011), Vol. 35, pp. 804-817, Neuroscience & biobehavioral reviews, Oxford, England, C1-1
M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, C Allwang, H Cobb, A Bush, I Schapkaitz, S Dodd, G Malhi
(2011), Vol. 135, pp. 389-394, Journal of affective disorders, Amsterdam, Netherlands, C1
Who's left? Symptoms of schizophrenia that predict clinical trial dropout
J Thompson, M Berk, O Dean, K Kohlmann, S Jeavons, A Bush, D Copolov
(2011), Vol. 26, pp. 609-613, Human psychopharmacology, West Sussex, England, C1-1
N-acetylcysteine for major depressive episodes in bipolar disorder
P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk
(2011), Vol. 33, pp. 374-378, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1
K Choy, O Dean, M Berk, A Bush, M van den Buuse
(2010), Vol. 649, pp. 224-228, European journal of pharmacology, Amsterdam, The Netherlands, C1-1
O Dean, A Bush, M Berk, D Copolov, M van den Buuse
(2010), Vol. 97, pp. 293-300, Pharmacology, biochemistry and behavior, Philadelphia, Pa., C1-1
Oxidative pathways as a drug target for the treatment of autism
K Villagonzalo, S Dodd, O Dean, K Gray, B Tonge, M Berk
(2010), Vol. 14, pp. 1301-1310, Expert opinion on therapeutic targets, London, England, C1-1
M Berk, S Dodd, O Dean, K Kohlmann, L Berk, G Malhi
(2010), Vol. 22, pp. 237-242, Acta neuropsychiatrica, Oxford, England, C1-1
Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting
M Berk, S Jeavons, O Dean, S Dodd, K Moss, C Gama, G Malhi
(2009), Vol. 14, pp. 357-360, CNS spectrums, New York, N.Y., C1-1
Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
O Dean, A Bush, M Berk, D Copolov, M van den Buuse
(2009), Vol. 198, pp. 258-262, Behavioural brain research, Amsterdam, The Netherlands, C1-1
O Dean, M van den Buuse, A Bush, D Copolov, F Ng, S Dodd, M Berk
(2009), Vol. 16, pp. 2965-2976, Current medicinal chemistry, Schiphol, The Netherlands, C1-1
M Bernardo, S Dodd, C Gama, D Copolov, O Dean, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush, M Berk
(2009), Vol. 21, pp. 239-245, Acta neuropsychiatrica, Oxford, England, C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush
(2008), Vol. 64, pp. 468-475, Biological psychiatry, Philadelphia, Pa., C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush
(2008), Vol. 64, pp. 361-368, Biological psychiatry, Philadelphia, Pa., C1-1
Glutathione : a novel treatment target in psychiatry
M Berk, F Ng, O Dean, S Dodd, A Bush
(2008), Vol. 29, pp. 346-351, Trends in pharmacological sciences, London, England, C1-1
Oxidative stress in psychiatric disorders : evidence base and therapeutic implications
F Ng, M Berk, O Dean, A Bush
(2008), Vol. 11, pp. 851-876, International journal of neuropsychopharmacology, Cambridge, England, C1-1
N-acetylcysteine for antioxidant therapy : pharmacology and clinical utility
S Dodd, O Dean, D Copolov, G Malhi, M Berk
(2008), Vol. 8, pp. 1955-1962, Expert opinion on biological therapy, London, England, C1-1
M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush
(2008), Vol. 64, pp. 361-368, Biological Psychiatry, Philadelphia, Pa., C1-1
A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use
S Jespersen, M Berk, C Van Wyk, O Dean, S Dodd, C Szabo, C Maud
(2004), Vol. 19, pp. 161-164, International clinical psychopharmacology, Philadelphia, Pa., C1-1
Funded Projects at Deakin
Australian Competitive Grants
The Efficacy of N-acetylcysteine as an Adjunctive Treatment in Bipolar Depression: A Double-blind, Randomised, Placebo-controlled Trial
Prof Michael Berk, A/Prof Olivia Dean, A/Prof Susan Cotton, Dr Seetal Dodd, Prof Gin Malhi, A/Prof Chee Ng
NHMRC Project Grant
- 2015: $69,545
- 2014: $169,437
- 2013: $74,883
- 2012: $197,858
The Efficacy of N-acetylcysteine as an adjunctive treatment in unipolar depression
Prof Michael Berk, Prof Gin Malhi, Dr Seetal Dodd, A/Prof Olivia Dean
NHMRC Project Grant
- 2012: $32,725
- 2011: $48,924
Proof of principle of the inflammatory and oxidative theory of depression: A treatment study
Prof Michael Berk, Dr Andrew Chanen, Ms Susan Harrigan, Christopher Davey, Dr Sarah Hetrick, A/Prof Olivia Dean, Dr Seetal Dodd
NHMRC Project Grant
- 2018: $20,933
- 2017: $102,975
- 2016: $152,181
- 2015: $110,745
- 2014: $111,704
- 2013: $105,227
- 2012: $26,547
The efficacy of adjunctive Garcinia mangostana Linn. pericarp for bipolar depression: A 24-week double-blind, randomized, placebo-controlled trial.
A/Prof Olivia Dean, Prof Michael Berk, Prof Chee Ng, Dr Seetal Dodd, Prof Malcolm Hopwood, Dr Alyna Turner, Prof Felice Jacka
NHMRC Project Grant
- 2020: $76,202
- 2019: $264,142
- 2018: $342,644
- 2017: $209,758
Integrated exploration of novel therapies for depression
A/Prof Olivia Dean
NHMRC CDF - Career Development Fellowship
- 2021: $126,121
- 2020: $124,380
- 2019: $122,663
- 2018: $120,850
The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine ('ice'¿) dependence
A/Prof Rebecca McKetin, A/Prof Olivia Dean, Prof Dan Lubman, Prof Paul Dietze, Dr Peter Higgs, Dr Peter Kelly, Dr Alyna Turner, Dr Brendan Quinn, Prof Greg Carter
NHMRC Project Grant
- 2019: $138,332
- 2018: $153,853
- 2017: $71,859
CREDIT: The CRE for the Development of Innovative Therapies for Psychiatric Disorders
Prof Michael Berk, Prof John McGrath, Prof Patrick McGorry, Prof John McNeil, Prof Gin Malhi, Prof Felice Jacka, A/Prof Susan Cotton, Prof Ken Walder, A/Prof Olivia Dean, Prof Lana Williams
NHMRC - Centres of Research Excellence
- 2023: $162,462
- 2022: $498,725
- 2021: $563,659
- 2020: $576,585
- 2019: $510,344
Mental Health Australia General Clinical Trial Network (MAGNET)
Prof Michael Berk, Prof Susan Rossell, Dr Paul Fitzgerald, Prof Adrienne O'Neil, Dr Alyna Turner, Prof undefined Rodgers, Prof Cathy Mihalopoulos, Prof Chee Ng, Dr Christopher Davey, Prof Cherrie Galletly, Prof Anthony Harris, Prof Christos Pantelis, Prof Colleen Loo, Prof Daniel Lubman, Prof Dan Siskind, Prof David Forbes, Prof Denise Meyer, Prof Felice Jacka, A/Prof Frances Kay-Lambkin, Prof Gin Malhi, Prof Greg Murray, Prof Helen Christensen, Prof Jayashri Kulkarni, Prof Jerome Sarris, Prof Jim Lagopoulos, Prof John McGrath, Dr Kate Hoy, Prof Katherine Mills, Prof Mark Nelson, Prof Meaghan O'Donnell, Prof Jane Gunn, Dr Michael Millard, Prof Michael Kyrios, Prof Murat Yucel, Prof Nicholas Glozier, Prof Nicholas Martin, A/Prof Olivia Dean, Prof Osvaldo Almeida, A/Prof Philip Batterham, A/Prof Rebecca McKetin, Prof Richard Bryan, Prof Richard Osborne, Dr Samuel Harvey, Prof Sean Hood, Prof Stephen Touyz, Prof Suresh Sundram, Prof Vasso Apostolopoulos, A/Prof Sophia Zoungas, Prof Svetha Venkatesh, Sarah Russell
MRFF Million Minds Mission Grant Opportunity
- 2023: $5,407,352
- 2022: $1,936,399
- 2021: $1,478,704
Other Public Sector Funding
Refrigerated Centrifuge and Vortex
Prof Michael Berk, A/Prof Olivia Dean
NHMRC - Equipment Grant (pre 2017)
- 2015: $8,187
The mental health data-sharing node: HeSANDA
Prof Alison Yung, Prof Peter Vuillermin, Prof Michael Berk, A/Prof Olivia Dean
ARDC Health Studies National Data Asset Program - Australian Research Data Commons
- 2023: $60,000
- 2022: $60,000
- 2021: $120,000
Industry and Other Funding
Efficacy of N-Acetyl Cysteine in Autism: A double blind, placebo-controlled randomised trial
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Katherine Gray, Prof Bruce Tonge
Simons Foundation Autism Research Initiative
- 2013: $143,821
- 2012: $119,640
The Efficacy of Minocycline as an Adjunctive Treatment in Unipolar Depression: A Pilot Study
A/Prof Olivia Dean
Australasian Society for Bipolar and Depressive Disorders Ltd
- 2014: $10,000
- 2013: $10,000
- 2012: $10,000
The efficacy of minocycline as an adjunctive therapy for unipolar depression: A pilot study.
A/Prof Olivia Dean
NARSAD - Young Investigator Award
- 2014: $35,973
- 2013: $13,966
The efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for the treatment of Schizophrenia: A double-blind, randomized, placebo controlled trial.
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean, Dr Alyna Turner, A/Prof Susan Cotton, Prof John McGrath, Dr Frances Dark
SMRI - Treatment Trials - Stanley Medical Research Institute
- 2021: $117,491
- 2019: $96,709
- 2018: $167,831
- 2017: $363,170
- 2016: $239,559
Exploring inflammation in depression ¿ Minocycline compared with N-acetyl cysteine.
A/Prof Olivia Dean
Australasian Society for Bipolar and Depressive Disorders Ltd
- 2017: $10,000
- 2016: $20,000
The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial
A/Prof Olivia Dean, Dr Melanie Ashton
Australasian Society for Bipolar and Depressive Disorders Ltd
- 2017: $4,250
- 2016: $30,000
The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial
A/Prof Olivia Dean, Prof Michael Berk, Dr Melanie Ashton
Australian Rotary Health - Ian Parker Bipolar Fund Scholarship
- 2019: $15,750
- 2018: $17,000
- 2017: $13,136
- 2016: $3,863
Can we reduce tobacco smoking using N-acetylcysteine as a cessation treatment?
Prof Michael Berk, Dr Seetal Dodd, A/Prof Olivia Dean
Harry Windsor Research Grant
- 2018: $25,000
- 2017: $25,000
Trisno Family Postdoctoral Mental Health Research Fellowship
A/Prof Olivia Dean
Trisno Family Fellowship
- 2022: $30,000
- 2021: $30,000
- 2019: $30,000
"Resuming Employment after Stroke: Enhancement through Telecoordination" - RESET Rural Expansion
Dr Alyna Turner, A/Prof Olivia Dean, Dr Alison Kennedy, Dr Mohammadreza Mohebbi, Dr Lan Gao
Stroke Foundation Research Grant
- 2021: $74,945
A Listening and Learning Healthcare System approach to improve outcomes for acute-care mental health consumers in the Barwon-Southwest Victoria Region.
Prof Anna Peeters, Prof Steven Allender, Prof Sharon Brennan-Olsen, Prof Michael Berk, A/Prof Olivia Dean, Prof Felice Jacka, Prof Adrienne O'Neil, A/Prof Melissa O'Shea, Prof Rajesh Vasa, A/Prof Michael Johnstone, A/Prof Martin Hensher, Dr Josh Hayward, Dr Elijah Marangu, Prof Alison Hutchinson, Dr Mary Lou Chatterton, Miss Sally Buchanan-Hagen
Western Alliance
- 2023: $79,045
- 2021: $118,568
Western Alliance and CARN collaboration - cofounding a lived experience position.
A/Prof Olivia Dean
McIntosh Family, Western Alliance
- 2022: $50,000
Other Funding Sources
Snijders Labs EvoSafe VF475-86 Upright Freezer - Olivia Dean
A/Prof Olivia Dean
NHMRC - Equipment Grant - Not R&D income countable (2017-current)
- 2021: $22,516
Supervisions
Melanie Ashton
Thesis entitled: Exploring factors that contribute to treatment response in bipolar depression
Doctor of Philosophy (Medicine), School of Medicine
Anna Lena Wrobel
Thesis entitled: The Role of Trauma in the Treatment of Bipolar Disorder
Doctor of Philosophy (Medicine), School of Medicine
Lauren Arancini
Thesis entitled: Predictors of Successful Tobacco Smoking Cessation
Doctor of Philosophy (Medicine), School of Medicine
Bianca Kavanagh
Thesis entitled: Impact of Personality Disorder on Health, Functioning, and Treatment Outcomes
Doctor of Philosophy (Medicine), School of Medicine
Declan Bourke
Thesis entitled: Predictors and moderators of treatment efficacy for childhood disruptive behaviours
Doctor of Psychology (Clinical), School of Psychology
David Robert Skvarc
Thesis entitled: The Post-Anaesthesia N-Acetyl-Cysteine Cognitive Evaluation (PANACEA) trial
Doctor of Philosophy (Psychology), School of Psychology
Kyoko Hasebe
Thesis entitled: Investigating Neurobiological Mechanisms Linking Depression and Inflammation
Doctor of Philosophy (Medicine), School of Medicine